|
AU775373B2
(en)
|
1999-10-01 |
2004-07-29 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
US6362217B2
(en)
|
2000-03-17 |
2002-03-26 |
Bristol-Myers Squibb Company |
Taxane anticancer agents
|
|
WO2001098286A1
(en)
|
2000-06-22 |
2001-12-27 |
Nitromed, Inc. |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
|
EP2108362B1
(en)
|
2002-06-26 |
2013-05-29 |
MediGene AG |
A cationic liposomal preparation comprising a taxane
|
|
US20070172446A1
(en)
|
2003-05-16 |
2007-07-26 |
Intermune, Inc. |
Synthetic chemokine receptor ligands and methods of use thereof
|
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
WO2006089209A2
(en)
|
2005-02-17 |
2006-08-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
|
|
MX2008011978A
(es)
|
2006-03-22 |
2009-04-22 |
Medigene Ag |
Tratamiento del cancer de seno negativo al triple receptor.
|
|
PL217731B1
(pl)
|
2006-06-01 |
2014-08-29 |
Tomasz Byrski |
Sposób wykrywania genetycznie uwarunkowanej obniżonej odpowiedzi na chemioterapię cytostatykiem taksanowym, zastosowanie mutacji założycielskiej oraz zestawu do wykrywania takiej odpowiedzi
|
|
WO2009143454A2
(en)
|
2008-05-22 |
2009-11-26 |
Kereos, Inc. |
Combination antitumor therapy
|
|
EP2310507A4
(en)
|
2008-07-08 |
2013-03-20 |
David Gladstone Inst |
METHOD AND COMPOSITIONS FOR ANGIOGENIC MODULATION
|
|
CN102040570B
(zh)
*
|
2009-10-14 |
2014-07-30 |
江苏先声药物研究有限公司 |
硫代紫杉烷类衍生物及其制备方法和用途
|
|
CN104582717B
(zh)
|
2012-07-19 |
2018-03-13 |
雷德伍德生物科技股份有限公司 |
对cd22有特异性的抗体及其使用方法
|
|
JP2016500058A
(ja)
|
2012-11-12 |
2016-01-07 |
レッドウッド バイオサイエンス， インコーポレイテッド |
化合物および抱合体を生成するための方法
|
|
LT2956175T
(lt)
|
2013-02-15 |
2017-12-11 |
The Regents Of The University Of California |
Chimerinis antigeno receptorius ir jo panaudojimo būdai
|
|
EP2970124B1
(en)
|
2013-03-14 |
2019-05-22 |
The Board of Trustees of the Leland Stanford Junior University |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
|
WO2015081282A1
(en)
|
2013-11-27 |
2015-06-04 |
Redwood Bioscience, Inc. |
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
|
|
PL3107899T3
(pl)
|
2014-02-19 |
2021-01-25 |
Aviv Therapeutics, Inc. |
Policykliczne amidy wiążące mitochondrialną dehydrogenazę aldehydową-2 (aldh2) i ich zastosowanie w leczeniu nowotworów
|
|
TW202515912A
(zh)
|
2014-03-21 |
2025-04-16 |
美商艾伯維有限公司 |
抗-egfr抗體及抗體藥物結合物
|
|
US10654875B2
(en)
|
2015-11-12 |
2020-05-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
|
|
US20210206826A1
(en)
|
2015-11-19 |
2021-07-08 |
The Regents Of The University Of California |
Conditionally repressible immune cell receptors and methods of use thereof
|
|
TWI760319B
(zh)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
乳癌治療
|
|
EP3231421A1
(en)
|
2016-04-11 |
2017-10-18 |
Greenaltech, S.L. |
Uses of a carotenoid in the treatment or prevention of stress induced conditions
|
|
KR20180135458A
(ko)
|
2016-04-26 |
2018-12-20 |
알.피.쉐러 테크놀러지즈 엘엘씨 |
항체 컨쥬게이트 및 이의 제조 및 이용 방법
|
|
DK3463308T3
(da)
|
2016-06-01 |
2022-01-31 |
Servier Ip Uk Ltd |
Formuleringer af polyalkylenoxid-asparaginase og fremgangsmåder til fremstilling og anvendelse deraf
|
|
JP2019526529A
(ja)
|
2016-06-08 |
2019-09-19 |
アッヴィ・インコーポレイテッド |
抗ｂ７−ｈ３抗体及び抗体薬物コンジュゲート
|
|
US20200002432A1
(en)
|
2016-06-08 |
2020-01-02 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
|
AU2017279554A1
(en)
|
2016-06-08 |
2019-01-03 |
Abbvie Inc. |
Anti-B7-H3 antibodies and antibody drug conjugates
|
|
ES2861499T3
(es)
|
2016-06-08 |
2021-10-06 |
Abbvie Inc |
Anticuerpos anti-B7-H3 y conjugados anticuerpo-fármaco
|
|
US20200147235A1
(en)
|
2016-06-08 |
2020-05-14 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
|
TWI852903B
(zh)
|
2017-01-05 |
2024-08-21 |
杏國新藥股份有限公司 |
胰臟癌治療
|
|
KR20190130559A
(ko)
|
2017-01-18 |
2019-11-22 |
에프1 온콜로지, 인코포레이티드 |
Axl 또는 ror2에 대한 키메라 항원 수용체 및 이의 사용 방법
|
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
CN111065623B9
(zh)
|
2017-05-24 |
2024-10-25 |
德克萨斯州大学系统董事会 |
用于抗体药物缀合物的接头
|
|
CN110003142A
(zh)
*
|
2018-01-04 |
2019-07-12 |
深圳福山生物科技有限公司 |
一种硒氰化合物及其用途
|
|
EA202091832A1
(ru)
|
2018-01-31 |
2021-01-11 |
ГАЛЕРА ЛЭБЗ, ЭлЭлСи |
Комбинированная терапия злокачественных новообразований макроциклическим кольцевым комплексом пентаазы и противоопухолевым агентом на основе платины
|
|
WO2019195596A1
(en)
|
2018-04-06 |
2019-10-10 |
The Regents Of The University Of California |
Methods of treating glioblastomas
|
|
AU2019249215A1
(en)
|
2018-04-06 |
2020-10-22 |
The Regents Of The University Of California |
Methods of treating EGFRvIII expressing glioblastomas
|
|
WO2019200181A1
(en)
|
2018-04-11 |
2019-10-17 |
Ohio State Innovation Foundation |
Methods and compositions for sustained release microparticles for ocular drug delivery
|
|
CA3105879A1
(en)
|
2018-07-18 |
2020-01-23 |
Manzanita Pharmaceuticals, Inc. |
Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
|
|
KR20220004653A
(ko)
|
2019-04-02 |
2022-01-11 |
켄조케티 바이오테크놀러지 인코포레이티드 |
유출 펌프-암 항원 다중특이적 항체 및 그것과 관련된 조성물, 시약, 키트 및 방법
|
|
CN115023443A
(zh)
|
2020-01-29 |
2022-09-06 |
肯乔克蒂生物技术股份有限公司 |
抗mdr1抗体及其用途
|
|
CA3182969A1
(en)
|
2020-06-04 |
2021-12-09 |
Kenjockety Biotechnology, Inc. |
Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
|
AU2021284240A1
(en)
|
2020-06-04 |
2022-12-08 |
William Robert ARATHOON |
Anti-ABCG2 antibodies and uses thereof
|
|
JP2023539883A
(ja)
|
2020-09-02 |
2023-09-20 |
ケンジョッケティ バイオテクノロジー，インク． |
抗ａｂｃｃ１抗体及びその使用
|
|
US20240010747A1
(en)
|
2020-11-13 |
2024-01-11 |
Kenjockety Biotechnology, Inc. |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
|
EP4247829A1
(en)
|
2020-11-20 |
2023-09-27 |
R.P. Scherer Technologies, LLC |
Glycoside dual-cleavage linkers for antibody-drug conjugates
|
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
AU2022413942A1
(en)
|
2021-12-13 |
2024-05-30 |
William Robert Arathoon Living Trust Dated August 29, 2016 |
Anti-abcb1 antibodies
|
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|